Latest ArticlesNanoemulsification technology was applied to improve the solubility and oral absorption behaviors of the insoluble Chinese medicine curcumin(1), achieving an efficient therapeutic effect for colorectal cancer. The nanoemulsion loaded with 1 was prepared through high-shear emulsification. The observation of transmission electron microscopy showed that the 1 nanoemulsion was spherical, and its particle size was (98.79±1.08)nm. After in vitro simulated digestion, (71.03±2.93)% of 1 was still dissolved in the aqueous phase. Moreover, intestinal absorption and pharmacokinetic experiments in vivo revealed that the nanoemulsion could promote the intestinal absorption of 1, especially in the duodenum segment. The 1-loaded nanoemulsion also exhibited the pharmacokinetic characteristics of fast absorption and slow elimination, and the relative oral bioavailability of 1 was improved to 313.50%. In the orthotopic nude mouse models of colorectal cancer, 1 nanoemulsion could effectively inhibit the tumor growth after oral administration. The weight of harvested tumor tissue in the 1 nanoemulsion treatment group was about 23.91% of that in the phosphate buffer treatment group, indicating that 1 nanoemulsion had an excellent therapeutic prospect in treating orthotopic colorectal cancer.
Using glycyrrhetinic acid(GA)-doxorubicin(1)-triphenylphosphine(TPP) as a model drug, a targeted mitochondrial delivery system, namely the hyaluronic acid(HA)-modification cationic liposomes(LP-G1T@HA), was constructed by the film dispersion method. Moreover, its pharmacologically related properties and antitumor activity in vitro were evaluated. The results showed that the particle size and encapsulation rate of the LP-G1T@HA were(340.3±2.3)nm and (85.4±3.1)%, respectively, and it showed good in vitro serum stability and low hemolytic toxicity. In vitro cell experiments demonstrated that LP-G1T@HA significantly inhibited the proliferation of MCF-7 breast cancer cells, induced the mitochondrial permeability transition pore(MPTP) opening, and accelerated cell apoptosis, suggesting that LP-G1T@HA could be used as an efficient mitochondrial-targeted delivery system to achieve an efficient antitumor effect.
To improve the water solubility of meloxicam(1), its nanosuspension was prepared by ultrasonic-assisted precipitation method. The formulation and process parameters were optimized by single factor test. The optimal formulation process was as follows: 0.2% of poloxamer 188 and 0.2% of hydroxypropyl methylcellulose(HPMC) were used as the combined stabilizers, the volume ratio of water to oil phase was 30∶1, the ultrasonic power ratio was 50%, and the ultrasonic time was 35 min. The particle size, polydispersity index(PDI) and ζ potential of the optimal 1 nanosuspension were 263.8 nm, 0.189 and–20.54 mV, respectively. After reconstruction of the freeze-dried powder of 1 nanosuspension, the particle size and PDI increased while ζ potential decreased compared with the 1 nanosuspension before lyophilization. The results of transmission electron microscopy(TEM) and X-ray diffraction(XRD) showed that 1 existed in the form of original crystal in the nanosuspension. The molecular dynamic simulation results showed that intermolecular hydrogen bonds were formed between the drug, poloxamer 188, and HPMC. The in vitro dissolution results showed that the dissolution rate and degree of 1 from the nanosuspension in pH 6.0 and pH 6.8 phosphate buffer solutions were significantly higher than those of the bulk drug and its physical mixture with the combined stabilizers.
To improve the stability of ambroxol hydrochloride and clenbuterol hydrochloride oral solution, a full factorial design of experiment was used to analyze the influences of type and amount of sweeteners on stability of the title oral solution. The results showed that the lower amounts of the sweeteners used, the more stable the ambroxol hydrochloride and clenbuterol hydrochloride oral solution would be. And, formaldehyde in the sweeteners was a key substance that affected the stability of ambroxol hydrochloride. By optimizing the source and amount of sweeteners and reducing the content of formaldehyde in the solution, impurity contents in the title oral solution could be reduced. Meanwhile, a prediction model was established based on the experimental data of stability tests. It was predicted that the impurity E content in the self-made ambroxol hydrochloride and clenbuterol hydrochloride oral solution would reach 0.2% in about 3.64 years when the samples were stored at 25 ℃.
Taking the initial tack, peeling strength, cohesion and comprehensive physical performance of the matrix as evaluation indicators, the types and amounts of the components of the blank matrix of the gel were screened and optimized by single factor test and Box-Behnken design-response surface methodology. The results showed that the optimal composition for the blank matrix of the composite traditional Chinese medicine cataplasm for external use was as follows: 6.14% of sodium polyacrylate NP700, 4.06% of sodium polyacrylate N500, 0.21% of aluminum glycinate and 24.05% of glycerin. The optimal composite traditional Chinese medicine cataplasm had a smooth appearance, good formability and viscoelasticity.
Applying the concept of “quality by design”, an initial risk assessment of various formulation variables of alfacalcidol soft capsules affecting disintegration time was conducted. The potential high-risk variables, including gelatin type, the mass ratio of gelatin to glycerol to water, and the amount of titanium dioxide used as opacifier, were obtained from the risk analysis. Single factor tests were carried out to optimize these variables with commercially available alfacalcidol soft capsules as the control. The optimal soft capsules were prepared with gelatin(180LB8) in a 1∶0.30∶1 mass ratio of gelatin to glycerol to water, and each soft capsule shell contained 2.5 mg of titanium dioxide. The disintegration time of the self-made soft capsules stored under accelerated conditions for 1 month did not significantly change, which was close to the control soft capsules stored at the same condition.
In this study, a gallic acid-modified chitosan hydrogel system was constructed, and its in vitro antibacterial capability, inhibition effects on bacterial biofilm and extracellular polysaccharides were investigated. Gallic acid modified chitosan(CS-GA) was synthesized by amide reaction, and the CS-GA hydrogel was formed by dissolving in water. The structure of CS-GA was confirmed by the infrared spectroscopy, ultraviolet spectroscopy, and 1H nuclear magnetic resonance(NMR) spectroscopy. Moreover, the grafting efficiency of gallic acid in CS-GA was (52.94±0.62)%, measured by UV-Vis. Then the inhibition effect of CS-GA on the bacterial biofilm and extracellular polysaccharides were investigated with Escherichia coli and Staphylococcus epidermidis as models. The inhibition rates of the CS-GA hydrogel at 32 mg/mL against bacterial biofilm and extracellular polysaccharide of E. coli were (81.91±0.00)% and (29.57±3.00)%, respectively; while for S. epidermidis were (52.86±0.01)% and (37.14±0.31)%, respectively. The results indicated that the constructed GA-CS hydrogel showed good inhibition effects on bacterial biofilm and extracellular polysaccharides.
The volatile oils of hemp were extracted by steam distillation and the gas chromatography-flame ionization detection(GC-FID) method was established to determine the main components including β-caryophyllene(1),α-caryophyllene(2) and caryophyllene oxide(3) with n-tridecane(4) as the internal standard. The results showed that this method had good resolution and specificity. It was linear for 1 - 3 in the concentration ranges of 0.001 7 - 0.174 8,0.001 7 - 0.170 0, 0.001 8 - 0.178 4 mg/mL, respectively. The detection limits of 1 – 3 were 0.087, 0.085, 0.180 μg/mL, respectively. The average sample recoveries(n=9) were 107.12%, 99.01% and 93.30%, with the RSDs of 2.33%, 1.14% and 1.61%, respectively. This method can be used for the determination of 1 - 3 in the volatile oils of hemp and provides a technical support for its quality control and medical application research.